Nasdaq
$0.5757▲ 0.30%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $3.0MShares out 5.2M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
24- 4d agoRegular26.10.20 23:096-KKey event#●●●#●●●#●●●
Scinai Immunotherapeutics Ltd.Bullish
Scinai Immunotherapeutics has extended its operating runway to late 2027 following the completion of recent financing and a new CDMO agreement. The company raised approximately $5.3 million in combined net proceeds through mid-October and secured $5.1 million in committed base service fees from a new contract. Management intends to use these resources to support business growth and pursue long-term profitability.…more
$0.5757+0.30%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.16Regular26.10.16 23:056-KKey event
Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics has closed a $4.0 million financing round through a private placement and warrant inducement. The transaction includes the issuance of 2,458,334 ADSs, the immediate exercise of existing warrants, and the issuance of new Series A-1 warrants, with proceeds intended to support CDMO operations and the immunotherapy pipeline.…more
$0.5757+0.30%vs prev closeView filingShare - 10.15Regular26.10.15 22:406-KKey event
Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics raised approximately $4 million through a private placement of 2,458,334 ADSs (or pre-funded warrants) and warrants to acquire up to 3,687,501 ADSs. The company also entered into a warrant inducement agreement to facilitate the exercise of existing warrants, issuing additional warrants in the process. Proceeds will be used to support the expansion of its CDMO platform and advance its immunotherapy pipeline.…more
$0.5757+0.30%vs prev closeView filingShare
23 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.14Pre-market26.10.14 21:03Bullish#●●●#●●●#●●●
Scinai Immunotherapeutics Announces $4M Financing via Private Placement…more
Scinai Immunotherapeutics is raising approximately $4 million through a private placement priced at $1.20 per ADS and a warrant inducement. The issuance of new securities may lead to potential dilution for existing shareholders.…more
$0.5757+0.30%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 10.13Regular26.10.14 02:18
●●●●●●●● ●●●●● ●●●●●●
Scinai Immunotherapeutics has entered into a $5.1 million clinical development and manufacturing agreement with a U.S.-based biopharmaceutical company, significantly boosting its order backlog. However, the stock remains a highly speculative micro-cap, making it susceptible to extreme price volatility.…more
$0.5757+0.30%vs prev closeShareBenzinga - 10.13Pre-market26.10.13 20:05
●●●●●●●● ●●●●● ●●●●●●
Scinai has secured a $5.1 million contract for drug development and clinical manufacturing, marking an expansion of its CDMO business. This contract provides a concrete revenue stream and supports the company's growth strategy.…more
$0.5757+0.30%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report